{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:27:17Z","timestamp":1790267237695,"version":"4.1.0"},"reference-count":28,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Pathological complete response (pCR) following neoadjuvant therapy and surgery for locally advanced rectal cancer is associated with improved prognosis. Accurately predicting who will achieve pCR could theoretically eliminate the need for surgery for these patients. We aimed to compare pCR and non-pCR rectal cancer patients following neoadjuvant therapy, searching for clinical predictors for pCR and comparing oncological outcomes between these groups. Methods: This is a single-center retrospective analysis of all patients who underwent a curative-intent rectal resection between 2010 and 2020 for primary non-metastatic rectal cancer following neoadjuvant therapy. The cohort (263 patients) was divided into two groups according to the pathological results from surgery: the pCR group (53 patients) and the non-pCR group (210 patients). Results: The groups were similar in terms of baseline characteristics, clinical presentation, and staging, but tumors of the pCR group were significantly higher in the rectum (mean distance from the anal verge 7.92 cm versus 6.9 cm respectively, p = 0.04), and more of them were located at the posterior rectal wall (37.7% versus 24.3%, p = 0.049). Multivariate analysis found posterior location and tumor height to be significantly associated with pCR (OR 2.23, 95% CI 1.11\u20134.45, p = 0.023), (OR 1.14, 95% CI 1.03\u20131.27, p = 0.015). The 5-year overall survival was 95.6% in the pCR group compared with 87.5% in the non-pCR group (p = 0.09), and the 5-year disease-free survival was 92.7% versus 64.5%, respectively (p &lt; 0.001). Conclusions: Tumor location at the posterior wall of the rectum and higher tumor location were found to be associated with pCR. Patients achieving pCR demonstrate improved prognosis compared with non-pCR patients.<\/jats:p>","DOI":"10.3390\/jcm14124251","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:40:27Z","timestamp":1750056027000},"page":"4251","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors and Long-Term Outcomes of Pathological Complete Response Following Neoadjuvant Treatment and Radical Surgery for Locally Advanced Rectal Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"Dan","family":"Assaf","sequence":"first","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-2485","authenticated-orcid":false,"given":"Yaacov","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sheba Medical Center, Ramat Gan 5262000, Israel"},{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Margalit","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sheba Medical Center, Ramat Gan 5262000, Israel"},{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Shacham-Shmueli","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sheba Medical Center, Ramat Gan 5262000, Israel"},{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Bear","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Elbaz","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lebedayev","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Ram","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"},{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Anderson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Gruper","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-2307","authenticated-orcid":false,"given":"Michael","family":"Goldenshluger","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-9424","authenticated-orcid":false,"given":"Lior","family":"Segev","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sheba Medical Center, Ramat Gan 5262000, Israel"},{"name":"Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.27531","article-title":"Evolution of therapy for locally advanced rectal cancer","volume":"129","author":"Altomare","year":"2024","journal-title":"J. Surg. Onc"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3748\/wjg.v29.i6.1011","article-title":"Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer","volume":"29","author":"Kang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer:12-year follow-up of the multicenter, randomized controlled TME trial","volume":"12","author":"Marijnen","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1245\/s10434-017-5873-8","article-title":"Pathologic complete response rates after neoadjuvant treatment in rectal cancer: An analysis of the national cancer database","volume":"24","author":"Lorimer","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/DCR.0b013e3182837e5b","article-title":"Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer","volume":"56","author":"Huh","year":"2013","journal-title":"Dis. Colon. Rectum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total Neoadjuvant Therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"Oncologist"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00384-023-04376-y","article-title":"Efficacy and safety of total neoadjuvant therapy in locally advanced rectal cancer: A meta-analysis","volume":"38","author":"Xiong","year":"2023","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/SLA.0b013e3182759f1c","article-title":"Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy","volume":"256","author":"Smith","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"The 2017 European Society of Coloproctology (ESCP) Collaborating Group (2018). An international multicentric prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Color. Dis., 20, 33\u201346.","DOI":"10.1111\/codi.14376"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/bjs.8732","article-title":"Critical appraisal of the \u201cwait and see\u201d approach in rectal cancer for clinical complete responders after chemoradiation","volume":"99","author":"Beets","year":"2012","journal-title":"Br. J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00384-005-0749-y","article-title":"Can pathological complete response in the primary tumor following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilization of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?","volume":"21","author":"Hughes","year":"2006","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/cncr.22625","article-title":"Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer","volume":"109","author":"Das","year":"2007","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00384-016-2712-5","article-title":"A single institution\u2019s long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy","volume":"32","author":"Runau","year":"2017","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1971","DOI":"10.1097\/MD.0000000000001971","article-title":"Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation","volume":"94","author":"Han","year":"2015","journal-title":"Medicine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"Peeters","year":"2007","journal-title":"Ann. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.3748\/wjg.v25.i33.4945","article-title":"Prognostic value of preoperative carcinoembryonic antigen\/tumor size in rectal cancer","volume":"25","author":"Cai","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00384-009-0682-6","article-title":"Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"24","author":"Cejas","year":"2009","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1748-717X-8-43","article-title":"Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery","volume":"8","author":"Yang","year":"2013","journal-title":"Radiat. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/DCR.0b013e31828e5a72","article-title":"CEA: A predictor for pathologic complete response after neoadjuvant therapy for rectal cancer","volume":"56","author":"Wallin","year":"2013","journal-title":"Dis. Colon. Rectum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.4251\/wjgo.v16.i6.2520","article-title":"Predication of pathological complete response and prognosis in locally advanced rectal cancer","volume":"16","author":"Xu","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shin, J.K., Huh, J.W., Lee, W.Y., Yun, S.H., Kim, H.C., Cho, Y.B., and Park, Y.A. (2022). Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-10974-7"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhou, C., Wang, K., Zhang, X., Xiao, Y., Yang, C., Wang, J., Qu, F., Wang, X., Liu, M., and Gao, C. (2023). Assessing the predictive value of clinical factors to pathological complete response for locally advanced rectal cancer: An analysis of 124 patients. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1125470"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1245\/s10434-013-3010-x","article-title":"Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: It means more than you think!","volume":"20","author":"Stocchi","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.surg.2014.10.010","article-title":"Pathologic evaluation of the response of mesorectal positive nodes to preoperative chemoradiotherapy in patients with rectal cancer","volume":"157","author":"Beppu","year":"2015","journal-title":"Surgery"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Flom, E., Schultz, K.S., Pantel, H.J., and Leeds, I.L. (2023). The Predictors of Complete Pathologic Response in Rectal Cancer during the Total Neoadjuvant Therapy Era: A Systematic Review. Cancers, 15.","DOI":"10.3390\/cancers15245853"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:52:19Z","timestamp":1760032339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124251"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124251","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,15]]}}}